Background: Mycobacterium tuberculosis (MTB) causes tuberculosis (TB), which is a fatal disease. Cases of drug-resistant MTB have increased in recent years. In this study, we analyzed 7 sites of MTB DNA sequences, including the rpoB and inhA gene, to investigate the relationship between gene mutations and drug resistance in MTB. 
| INTRODUCTION
Although the incidence of tuberculosis (TB) in Korea has decreased over the last 50 years, the number of new cases increased from 35 000 in 2007 to 40 000 in 2011. 1, 2 Although bacterial culture and population surveillance are performed to prevent the spread of drugresistant strains, the nationwide incidence of multidrug-resistant (MDR) Mycobacterium tuberculosis (MTB) has exceeded the controllable limit. 3, 4 As such, preventing the spread of MDR bacteria and monitoring and controlling large-scale infections is a priority for the medical community and has important implications for public health policy. 5 Diagnosing TB infection in hospitals requires the culture of MTB, for which the US Centers for Disease Control and Prevention and WHO recommend liquid medium. [6] [7] [8] [9] The Korean Institute of Tuberculosis uses the absolute concentration method with Löwenstein-Jensen (LJ) medium to determine the minimum drug concentration that can inhibit the growth of susceptible wild-type MTB strains isolated from treatment-naive patients as well as the resistance of 20 colonies to the same drug concentration as the standard. 10 The transmission of drug-resistant MTB between individuals is a major challenge for healthcare professionals. The anti-TB susceptibility test can detect drug-resistant MTB strains, thus hastening patient diagnosis and treatment aside from preventing the development and spread of infection. 
| MATERIALS AND METHODS

| Sample collection
In this study, the clinical samples were obtained from cases that were urine. For this study, we retrospectively analyzed the results using these samples. Samples used for sequencing were collected from liquid culture.
| Culture
For solid cultures, 3% Ogawa medium (Eiken, Tokyo, Japan) was used.
Subsequently, examinations were conducted once every week, and the samples were cultured for up to 8 weeks to be confirmed as negative. If proliferation was observed, characteristics such as the color and shape of the colonies and their numbers were noted. The cultured strains were smear tested to confirm that they were acid-fast bacilli (AFB).
For liquid cultures, 7-mL Mycobacteria Growth Indicator Tube (MGIT; Becton Dickinson, Sparks, MD, USA) was used. The barcode of the inoculated MGIT tube was scanned using MGIT 960, and the tube was placed in the designated area with green lights and incubated for 42 days. The presence of AFB was confirmed via Ziehl-Neelsen staining; if AFB were observed, then we determined whether they were MTB or not.
| Antituberculosis drug susceptibility test
The suitable sample was sent to the Korean Institute of Tuberculosis laboratory for antituberculosis drug susceptibility test. Fresh MTB grown on solid medium for <15 days was used for the sensitivity test if at least 10 colonies were present. Drug susceptibility was evaluated based on the LJ medium absolute concentration method using an 
| Target gene selection and sequencing
We investigated the genetic basis for drug resistance in MTB by Table S1 . 
| Data analysis
| Ethics
This study did not require ethical approval because it is a retrospective analysis of the results of examinations for routine medical care. The study was conducted in conformance with the Declaration of Helsinki.
| RESULTS
| Drug susceptibility testing
We found that 13 of 74 (17.6%) of cases showed resistance to at least 1 of the 13 antibiotics tested. Most of the cases were resistant to INH (9 cases), followed by SM and RIF (7 and 6 cases, respectively) ( Figure 1 ).
| Sequencing results
Of the 74 cases tested, 13 were positive in the drug susceptibility test, and 12 (16.2%) were mutation positive. Genotype-phenotype comparisons revealed that 65 cases (87.8%) were matched in terms of antibiotic resistance, while 9 (12.2%) were not.
| Analysis of drug susceptibility and sequence data
We analyzed the ahpC, eis promoter, gyrA, inhA, katG, rpoB, and rrs genes in the 74 cases to identify drug resistance-related mutations.
The sequencing results indicated that these mutations were present in 12 cases. We found mutations in gyrA, katG, and rpoB in 2, 5, and 8 cases, respectively (Table 2 ). An Asp94Ala mutation (GAC→GCC) in (Table S2) . 
